Literature DB >> 23743184

Primary complement C5 deficiencies - molecular characterization and clinical review of two families.

Lone Schejbel1, Dag Fadnes, Henrik Permin, Knut Tore Lappegård, Peter Garred, Tom Eirik Mollnes.   

Abstract

Inherited deficiency states of the terminal complement component C5 are rare and often associated with increased risk of recurrent Neisseria infections. More than 50 cases with primary C5 deficiency have been reported. In spite of this, the molecular basis has only been documented in a few cases. In the present study we investigated two unrelated Caucasian probands with C5 deficiency originating from Norway and Denmark, respectively, and found three previously undescribed mutations. With these data, thirteen mutations associated with C5 deficiency have been described. By genetic screening of the family of the Norwegian patient, previously diagnosed as homozygous C5 deficient and suffering four Neisseria infections, an additional case of C5 deficiency was discovered, who had experienced one episode of Neisseria infections. Detailed review of the clinical history of the patients and their healthy relatives did not reveal any differences between C5 deficient and sufficient individuals with regard to clinical presentation, apart from the susceptibility to Neisseria infections. Of note, one of the patients described here, and several C5 deficient patients from the literature had Neisseria meningitidis serotype B infections, which is not covered by the current vaccines. These data support the clinical guidelines for patients treated with C5 inhibitors, who are functional C5 deficient by the treatment.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  C5; Complement; Deficiency; Meningococcal infection

Mesh:

Substances:

Year:  2013        PMID: 23743184     DOI: 10.1016/j.imbio.2013.04.021

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  11 in total

1.  Potentiation of complement regulator factor H protects human endothelial cells from complement attack in aHUS sera.

Authors:  Richard B Pouw; Mieke C Brouwer; Marlon de Gast; Anna E van Beek; Lambertus P van den Heuvel; Christoph Q Schmidt; Arie van der Ende; Pilar Sánchez-Corral; Taco W Kuijpers; Diana Wouters
Journal:  Blood Adv       Date:  2019-02-26

Review 2.  Unintended Immunological Consequences of Biologic Therapy.

Authors:  Sarah E Henrickson; Melanie A Ruffner; Mildred Kwan
Journal:  Curr Allergy Asthma Rep       Date:  2016-06       Impact factor: 4.806

3.  Complement factor 5 (C5) p.A252T mutation is prevalent in, but not restricted to, sub-Saharan Africa: implications for the susceptibility to meningococcal disease.

Authors:  C Franco-Jarava; D Comas; A Orren; M Hernández-González; R Colobran
Journal:  Clin Exp Immunol       Date:  2017-04-20       Impact factor: 4.330

Review 4.  Complement-Mediated Regulation of Metabolism and Basic Cellular Processes.

Authors:  Christoph Hess; Claudia Kemper
Journal:  Immunity       Date:  2016-08-16       Impact factor: 31.745

5.  Low Levels of Factor H Family Proteins During Meningococcal Disease Indicate Systemic Processes Rather Than Specific Depletion by Neisseria meningitidis.

Authors:  Anna E van Beek; Richard B Pouw; Victoria J Wright; Neneh Sallah; David Inwald; Clive Hoggart; Mieke C Brouwer; Rachel Galassini; John Thomas; Leo Calvo-Bado; Colin G Fink; Ilse Jongerius; Martin Hibberd; Diana Wouters; Michael Levin; Taco W Kuijpers
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

6.  Novel Mutations Causing C5 Deficiency in Three North-African Families.

Authors:  Roger Colobran; Clara Franco-Jarava; Andrea Martín-Nalda; Neus Baena; Elisabeth Gabau; Natàlia Padilla; Xavier de la Cruz; Ricardo Pujol-Borrell; David Comas; Pere Soler-Palacín; Manuel Hernández-González
Journal:  J Clin Immunol       Date:  2016-03-30       Impact factor: 8.317

Review 7.  The "ins and outs" of complement-driven immune responses.

Authors:  Simon Freeley; Claudia Kemper; Gaëlle Le Friec
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

8.  Recognition of Neisseria meningitidis by the long pentraxin PTX3 and its role as an endogenous adjuvant.

Authors:  Barbara Bottazzi; Laura Santini; Silvana Savino; Marzia M Giuliani; Ana I Dueñas Díez; Giuseppe Mancuso; Concetta Beninati; Marina Sironi; Sonia Valentino; Livija Deban; Cecilia Garlanda; Giuseppe Teti; Mariagrazia Pizza; Rino Rappuoli; Alberto Mantovani
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

Review 9.  Activated Complement Factors as Disease Markers for Sepsis.

Authors:  Jean Charchaflieh; Julie Rushbrook; Samrat Worah; Ming Zhang
Journal:  Dis Markers       Date:  2015-09-02       Impact factor: 3.434

10.  Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.

Authors:  Peter Garred; Andrea J Tenner; Tom E Mollnes
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.